Reversibility of the chronic effects of di(2-ethylhexyl)phthalate.
Fischer-344 rats treated with 12,500 ppm (728 and 879 mg/kg/d for male and females, respectively) and B6C3F1 mice treated with 6,000 ppm (1,227 and 1,408 mg/kg/d, respectively) di(2-ethylhexyl)phthalate (DEHP) in the diet for 78 weeks were allowed to recover for an additional 26 weeks on control diet. Blood was analyzed at weeks 78 and 104 from 10 animals per sex per group; animals were sacrificed at weeks 79 and 105 for histopathologic examination. The results are compared with data from animals continuously exposed to these dietary levels for 104 weeks (10, 11). Body weights and food consumption were measured monthly. BUN, albumin, and globulin that were significantly different for rats exposed to DEHP throughout 104 weeks, were comparable to controls for the recovery group. Reversibility of chronic effects on erythrocyte count, hemoglobin, and hematocrit values was apparent only for female rats. Chronic exposure demonstrated effects on liver, kidney, and testes weights. All organ weight effects except for testes for the Recovery group of rats, and all organ weight effects for mice, were reversible. Pigmentation of Kupffer cells and renal tubules present in chronically treated rats were not observed for the Recovery group. Lesions in the testes and pituitary gland were not reversible in rats. This may be a reflection of the senescence of the hypothalamic-gonad axis in rats. Cessation of exposure for mice resulted in amelioration of effects in the kidneys, liver, and testes. The extent of reversibility suggests that many chronic effects may be associated with a metabolic phenomenon such as peroxisome proliferation, which also reverted to control levels after 26 weeks of recovery.
David
R M
RM
Health and Environment Laboratories, Eastman Kodak Company, Rochester, New York 14652, USA. raymond.david@kodak.com
Moore
M R
MR
Finney
D C
DC
Guest
D
D
D000284:Administration, Oral; D000818:Animals; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D004051:Diethylhexyl Phthalate / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D008107:Liver Diseases / Q000097:blood / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009929:Organ Size / Q000187:drug effects; D010190:Pancreatic Neoplasms / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D020025:Peroxisome Proliferators / Q000494:pharmacology / Q000633:toxicity; D010900:Pituitary Diseases / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D051381:Rats; D011916:Rats, Inbred F344; D012709:Serum Albumin / Q000032:analysis; D012712:Serum Globulins / Q000032:analysis; D013733:Testicular Diseases / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D013997:Time Factors
D006454:Hemoglobins; D020025:Peroxisome Proliferators; D012709:Serum Albumin; D012712:Serum Globulins; D004051:Diethylhexyl Phthalate